ArticleJournal of eating disorders2025
Establishment of an international Consortium for Research in Eating Disorders (CoRe-ED): Analysis of early-stage participant involvement and expectations.
Article in Journal of eating disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEating disorders are a major global health concern. However, eating disorders research has been incorrectly labelled by some as "niche" and is critically underfunded throughout the world. With a plan to try to assist in addressing these issues and others, we launched the international not-for-profit Consortium for Research in Eating Disorders (CoRe-ED) in September 2024. CoRe-ED has a global mission to promote innovations in eating disorders research by empowering all voices and ultimately creating new therapies for all people experiencing eating disorders. The aim of the present study was to examine the broad characteristics of the individuals who joined CoRe-ED free of charge and their expected benefits and experiences in the earliest stages of CoRe-ED.
methodsCoRe-ED registrants completed a written online form between 25 September 2024 and 31 December 2024. As part of this registration process, they consented to deidentified aggregated data being used for research purposes. We analysed the registration data from 252 adult participants, particularly, their primary country of residence, their role(s) (e.g., researcher with lived experience) and their perceived expectations for benefits and experiences using inductive thematic analysis.
resultsThe CoRe-ED registrants came from 20 countries across five continents, with Australia being the most common country. The following roles were represented; researchers, health professionals, working in a not-for-profit/advocacy role, lived experience of an eating disorder either personally and/or as a carer/supporter, and working in industry, with researchers being the highest frequency group. Thematic analysis of perceived expectations for CoRe-ED resulted in seven major themes: (1) networking, connecting, and community building (2), research contribution and collaboration (3), learning, staying informed, and professional development (4), raising awareness and advocacy (5), facilitating innovations and advancements in practice and policy (6), sharing lived experience, and (7) gaining international insights and inspiration.
conclusionsOur findings suggested that our novel international eating disorder research consortium had attracted registrants across multiple continents and groups who broadly wished to network/build a community, contribute to research and receive education. Future research should examine longer term experiences to ensure that expectations are being met and that the broader global mission of CoRe-ED is being addressed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.